← Back to patent-cliff list
CAS 289475-77-0
2-amino-3-methyl-N-(2-morpholinoethyl)pentanamide
Codes: LM11A-31
Application context (from source-drug indications)
进行性核上性麻痹LM11A-31Alzheimer's diseaseLM11A-31
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| LM11A-31 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-amino-3-methyl-N-(2-morpholinoethyl)pentanamide→2-morpholinoethan-1-amine→2-((tert-butoxycarbonyl)amino)-3-methylpentanoic acid→tert-butyl (3-methyl-1-((2-morpholinoethyl)amino)-1-oxopentan-2-yl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.